Sight Diagnostics

About:

Sight Diagnostics is a medical platform for diagnosing blood diseases using digital fluorescent microscopy.

Website: http://www.sightdx.com

Top Investors: OurCrowd, Koch Disruptive Technologies, New Alliance Capital, Innovation Endeavors, GO CAPITAL

Description:

Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science. Sight’s first product, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents. *Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.